MSCT finds role in bone marrow lesion diagnosis

Article

Whole-body, low-dose CT studies of bone marrow lesions performed on 16-slice scanners are more sensitive, faster, and cheaper than conventional CT or MR imaging, according to researchers at the University of Munich's Institute of Clinical Radiology.

Whole-body, low-dose CT studies of bone marrow lesions performed on 16-slice scanners are more sensitive, faster, and cheaper than conventional CT or MR imaging, according to researchers at the University of Munich's Institute of Clinical Radiology.

Dr. Sonja Buhmann and colleagues evaluated 40 patients with proven multiple myeloma, who were divided in two groups of 20 each. Both groups underwent whole-body scanning, the first group with effective doses of 100 mAs and the other at 50 mAs.

The researchers detected all the osteolytic lesions in both groups and are now moving toward a standard 50-mAs dose protocol, Buhmann reported in a scientific session at the RSNA meeting.

Imaging protocols included 16-row scanning with 3-mm axial and sagittal slice reconstruction and 1.5 collimation at 120 kVp. At a mean radiation dose of 10 mSv and 5 mSv, respectively, each group had similarly acceptable image quality scores.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.